Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study
Open Access
- 21 May 2004
- Vol. 328 (7455) , 1535-1536
- https://doi.org/10.1136/bmj.38036.646030.ee
Abstract
Introduction Homozygosity for the T allele of the C677T polymorphism of the gene encoding the folate dependent enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) is a risk factor for neural tube defects.1 Both the homozygous (TT) and heterozygous (CT) genotypes are associated with lower tissue concentrations of folate, higher homocysteine concentrations, and lower enzyme activity than the wild type (CC) genotype; these effects are more marked in homozygotes. Low folate and raised homocysteine levels in early pregnancy are risk factors for neural tube defects.2 We investigated the possibility that the CT genotype would also increase the risk of these malformations.Keywords
This publication has 5 references indexed in Scilit:
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ, 2002
- Comorbidity of 5,10-methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk for neural tube defectsJournal of Medical Genetics, 2000
- 5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE ReviewAmerican Journal of Epidemiology, 2000
- The “Thermolabile” Variant of Methylenetetrahydrofolate Reductase and Neural Tube Defects: An Evaluation of Genetic Risk and the Relative Importance of the Genotypes of the Embryo and the MotherAmerican Journal of Human Genetics, 1999
- Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 1995